The Hidden Epidemic: Bartonella quintana's Reemergence in Canada

An ancient soldier's disease is now striking vulnerable populations in our cities

Public Health Infectious Disease Epidemiology

Introduction: From Trenches to City Streets

Imagine a disease that affected over a million soldiers during World War I, so notorious it was named "trench fever." For decades, this illness seemed confined to history books—but the bacterium behind it, Bartonella quintana, has quietly resurged in modern Canada. Recent research reveals this pathogen has established a disturbing foothold across the nation, from British Columbia to Quebec, with cases steadily increasing year after year 1 .

Key Finding

A 2024 study identified 33 individuals with confirmed B. quintana infections across seven provinces and one territory, with the highest numbers reported in 2022 and 2023 1 .

This isn't a historical curiosity—it's a contemporary public health challenge disproportionately affecting marginalized populations, particularly people experiencing homelessness and Indigenous communities with limited access to running water 1 .

What Is Bartonella quintana?

Bartonella quintana is a formidable intracellular Gram-negative bacterium that survives inside its host's cells 1 . It's transmitted through an unexpected vector: the human body louse (Pediculus humanus corporis) 1 .

Transmission Cycle

The infection spreads when body lice feed on human blood, then defecate. The bacterium-rich louse feces contaminate skin abrasions when scratching occurs, allowing B. quintana to enter the bloodstream 1 .

Risk Factors

This transmission mechanism explains why the infection thrives where access to hygiene facilities is limited—among people experiencing homelessness, in overcrowded settings, and in communities without running water 2 .

Body Lice vs. Head Lice

Body lice differ from head lice in both their habitat (clothing rather than hair) and their disease-carrying potential. While head lice are primarily a nuisance, body lice can carry dangerous pathogens including B. quintana 2 .

The Canadian Situation: A National Study Reveals the Truth

Research Methodology: Connecting Laboratory and Clinical Data

Canadian researchers employed a dual approach to understand B. quintana's footprint 1 :

  • Laboratory Analysis: Examination of seven years of testing data (2017-2023) from Canada's National Microbiology Laboratory, including qPCR results and antibody titers
  • Systematic Review: Comprehensive analysis of all published Canadian cases from 1915 to July 2024

This combination allowed scientists to see both confirmed laboratory cases and clinically reported infections that might not have been tested at the national laboratory.

Key Findings: A Nationwide Concern

The research revealed several troubling patterns:

7+

Provinces & territories with infections detected 1

33

qPCR-positive individuals identified 1

19%

Mortality rate among literature cases 1

Canadian B. quintana Cases by Data Source
Data Source Time Period Number of Cases Key Characteristics
National Microbiology Laboratory 2017-2023 33 qPCR-positive individuals Spread across 7 provinces and 1 territory
Systematic Literature Review 1915-2024 14 qPCR-positive + 7 probable cases 19% mortality, all from endocarditis
Case Trends Over Time

Clinical Manifestations: Beyond Trench Fever

While B. quintana originally earned its reputation causing trench fever—a relapsing febrile illness accompanied by headache, bone pain (particularly shin pain), and dizziness—we now know it causes a spectrum of conditions 4 :

Chronic Bacteremia

The bacterium can persist in the bloodstream for months or even years. One study documented bacteremia lasting up to 78 weeks 4 . This chronic infection often presents with minimal symptoms, allowing the bacteria to spread undetected.

Infective Endocarditis

Perhaps the most dangerous manifestation, B. quintana can infect heart valves, leading to life-threatening endocarditis. The 2024 Canadian study identified endocarditis as the cause of all B. quintana-related deaths in the systematic review 1 . This condition often requires valve replacement surgery and prolonged antibiotic treatment.

Bacillary Angiomatosis

In immunocompromised patients, B. quintana can cause bacillary angiomatosis—vascular proliferative lesions that resemble tumors in the skin and internal organs 4 .

Trench Fever

The classic presentation includes relapsing fever, severe headache, and bone pain (especially in the shins). While historically associated with soldiers, it now primarily affects marginalized urban populations 4 .

Spectrum of B. quintana Diseases
Disease Manifestation Key Symptoms At-Risk Populations
Trench Fever Relapsing fever, headache, shin pain Previously soldiers; now marginalized populations
Chronic Bacteremia Often minimal symptoms, prolonged infection People experiencing homelessness
Infective Endocarditis Heart failure, fever, cardiac murmur All populations, often with delayed diagnosis
Bacillary Angiomatosis Skin lesions resembling tumors Immunocompromised individuals

The Diagnostic Challenge: Why B. quintana Evades Detection

B. quintana presents significant diagnostic challenges that contribute to underrecognition:

Culture Difficulties

Unlike many bacteria, B. quintana doesn't grow in routine blood cultures incubated for five days 1 . Its intracellular location and slow replication (approximately 3 hours) require specialized culture techniques with prolonged incubation 1 .

Serologic Cross-Reactivity

Antibody tests for B. quintana often cross-react with B. henselae (the cat-scratch disease agent), making species-specific diagnosis difficult without additional testing 9 .

Molecular Advances

Modern molecular techniques like quantitative PCR (qPCR) have improved detection capabilities. Recent research has validated qPCR tests targeting specific B. quintana genes with 100% sensitivity and specificity 6 .

A Closer Look: The National Microbiology Laboratory Study

The 2024 Canadian study provides the most comprehensive picture of B. quintana infections in Canada to date. Here's how the research was conducted:

Methodology

Laboratory Data

Researchers analyzed all B. quintana testing performed at Canada's National Microbiology Laboratory from 2017-2023 for molecular testing and 2008-2023 for serologic testing 1 .

Systematic Review

Scientists searched multiple databases (PubMed, Scopus, Embase, Web of Science) for articles published before July 15, 2024, using terms related to B. quintana in Canada 1 .

Case Classification

Cases were classified as confirmed (species identification by qPCR) or probable (serologic positivity with compatible clinical syndrome and epidemiologic risk factors) 1 .

Key Results

The laboratory analysis revealed:

  • A statistically significant increase in cases over time (p-value = 0.005) 1
  • Increasing percent positivity for B. quintana qPCR tests (p-value = 0.036) 1
  • Rising median immunoglobulin G titers starting in 2017 1

The systematic review identified an additional 21 cases not captured in the NML data, highlighting how this infection likely remains underdiagnosed 1 .

Key Findings from the 2024 Canadian Study
Finding Statistical Significance Public Health Implication
Increasing case numbers p-value = 0.005 Ongoing transmission across geographic settings
Rising test positivity p-value = 0.036 Possibly reflecting increased prevalence or testing
National distribution 7 provinces + 1 territory Not a localized problem
Substantial mortality 19% among literature cases Need for earlier detection and treatment

Conclusion: A Call to Action

The reemergence of Bartonella quintana in Canada represents more than a microbiological curiosity—it serves as a marker of social inequality 1 . This disease thrives where poverty, overcrowding, and inadequate access to hygiene facilities converge 2 . The steady increase in cases signals ongoing transmission across diverse Canadian settings 1 .

Enhanced Clinical Awareness

Healthcare providers should consider B. quintana in patients from high-risk backgrounds with compatible symptoms

Improved Diagnostic Access

Expanding availability of molecular testing to improve detection

Public Health Interventions

Addressing the root causes through improved access to hygiene facilities, laundry services, and housing support

References